Search
Vedolizumab
Vedolizumab is a recombinant humanized IgG1 monoclonal antibody directed against the human lymphocyte α4β7 integrin, a key mediator of gastrointestinal inflammation implicated in diseases like ulcerative colitis or Crohn's disease. α4β7 integrin facilitates the interaction between lymphocytes and gut endothelial cel...
Moderate Ulcerative colitis
go.drugbank.com/conditions/DBCOND0020388Severe Crohn's Disease
go.drugbank.com/conditions/DBCOND0053724Severe Ulcerative Colitis
go.drugbank.com/conditions/DBCOND0033634Moderate Crohn’s Disease
go.drugbank.com/conditions/DBCOND0089473Etrolizumab
go.drugbank.com/drugs/DB12189InvestigationalA244579, A244584] A recent class of drugs designed to impair lymphocyte homing, so-called "anti-trafficking agents" (ATAs), have shown some success and include approved drugs such as [natalizumab] and [vedolizumab … Etrolizumab is a humanized IgG1κ monoclonal antibody directed against the β7 subunit of gastrointestinal α4β7 and αEβ7 integrins that, due to its target specificity, appears as or more efficacious than [vedolizumab